Matrix Metalloproteinase 17 [matrixová metaloproteinasa 17]
- Terms
-
matrix metaloproteináza 17
matrixová metaloproteináza 17
matrixová metaloproteináza membránového typu 4
metaloproteinasa MMP-17
metaloproteinasa MMP17
metaloproteináza MMP-17
metaloproteináza MMP17
MT-MMP-4
MT4-MMP
-
Membrane-Type 4 Matrix Metalloproteinase
Membrane-Type Matrix Metalloproteinase 4
MMP-17 Metalloproteinase
MMP17 Metalloproteinase
MT-MMP-4
MT4-Matrix Metalloproteinase
MT4-MMP
A membrane-type metalloproteinase that is associated with the CELL MEMBRANE via a GLYCOSYL-PHOSPHATIDYLINOSITOL linkage. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN.
- DUI
- D053515 MeSH Browser
- CUI
- M0485717
- History note
- 2007(2005)
- Public note
- 2007; MATRIX METALLOPROTEINASE 17 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 1994-2005
Combination
- antagonists & inhibitors
- Matrix Metalloproteinase Inhibitors
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0